You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ALKS 3831

Showing 1 - 25 of 50
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Focus of Study is on Healthy Lactating Women Trial in Las Vegas (LYBALVI)

Recruiting
  • Focus of Study is on Healthy Lactating Women
  • Las Vegas, Nevada
    Alkermes Investigator Site
Oct 7, 2022

Bipolar I Disorder, Schizophrenia Trial in Cincinnati, Everett (OLZ/SAM)

Enrolling by invitation
  • Bipolar I Disorder
  • Schizophrenia
  • Cincinnati, Ohio
  • +1 more
Feb 9, 2022

Schizophrenia, Bipolar I Disorder Trial in United States (OLZ/SAM, Olanzapine)

Recruiting
  • Schizophrenia
  • Bipolar I Disorder
  • Dothan, Alabama
  • +4 more
Aug 9, 2022

Schizophrenia, Schizophreniform Disorders, Bipolar I Disorder Trial in Worldwide (ALKS 3831, Olanzapine)

Completed
  • Schizophrenia
  • +2 more
  • Little Rock, Arkansas
  • +56 more
Jan 5, 2022

Bipolar I Disorder Trial in Cincinnati, Everett (OLZ/SAM)

Recruiting
  • Bipolar I Disorder
  • Cincinnati, Ohio
  • +1 more
Oct 5, 2021

Schizophrenia Trial in Puerto Rico, United States (ALKS 3831)

Completed
Has Results
  • Schizophrenia
  • ALKS 3831
  • Little Rock, Arkansas
  • +44 more
Jul 20, 2021

Schizophrenia, Schizophreniform Disorder, Bipolar I Disorder Trial in Worldwide (ALKS 3831)

Active, not recruiting
  • Schizophrenia
  • +2 more
  • ALKS 3831
  • Little Rock, Arkansas
  • +85 more
Feb 10, 2022

Schizophrenia, Alcohol Use Disorder Trial in Bulgaria, Poland, United States (Samidorphan + olanzapine (ALKS 3831), Placebo +

Completed
Has Results
  • Schizophrenia
  • Alcohol Use Disorder
  • Samidorphan + olanzapine (ALKS 3831)
  • Placebo + olanzapine
  • Little Rock, Arkansas
  • +70 more
Sep 14, 2021

Schizophrenia Trial in Bulgaria, Czechia, United States (Samidorphan (Low Dose), Samidorphan (Medium Dose), Samidorphan (High

Completed
Has Results
  • Schizophrenia
  • Samidorphan (Low Dose)
  • +4 more
  • Little Rock, Arkansas
  • +60 more
Sep 10, 2021

Schizophrenia Trial in Puerto Rico, United States (ALKS 3831, Olanzapine)

Completed
Has Results
  • Schizophrenia
  • Little Rock, Arkansas
  • +53 more
Jan 29, 2020

Schizophrenia Trial in Worldwide (ALKS 3831)

Completed
Has Results
  • Schizophrenia
  • ALKS 3831
  • Little Rock, Arkansas
  • +30 more
Jul 15, 2019

Advanced Solid Tumors Trial in Worldwide (ALKS 4230, ALKS 4230 + pembrolizumab)

Active, not recruiting
  • Advanced Solid Tumors
  • ALKS 4230
  • ALKS 4230 + pembrolizumab
  • Denver, Colorado
  • +30 more
Nov 23, 2022

Schizophrenia Trial in Worldwide (ALK3831, Olanzapine, Placebo)

Completed
Has Results
  • Schizophrenia
  • Little Rock, Arkansas
  • +30 more
May 25, 2018

Non-cutaneous Squamous Cell Carcinoma of Head and Neck Trial in United States (ALKS 4230, Pembrolizumab)

Completed
  • Non-cutaneous Squamous Cell Carcinoma of Head and Neck
  • Miami, Florida
  • +5 more
Nov 10, 2022

CNS Diseases Trial in Brisbane (Placebo, ALKS 1140)

Suspended
  • Central Nervous System Diseases
  • Placebo
  • ALKS 1140
  • Brisbane, Australia
    Alkermes Clinical Investigative Site
Feb 16, 2022

Advanced Solid Tumors Trial in Worldwide (ALKS 4230, Pembrolizumab)

Recruiting
  • Advanced Solid Tumors
  • ALKS 4230
  • Pembrolizumab
  • Los Angeles, California
  • +48 more
Feb 1, 2022

Refractory MDD Trial in Australia, Puerto Rico, United States (ALKS 5461)

Terminated
Has Results
  • Refractory Major Depressive Disorder
  • ALKS 5461
  • Tucson, Arizona
  • +33 more
Jun 29, 2021

Cutaneous Melanoma, Mucosal Melanoma Trial in Worldwide (Nemvaleukin Alfa Subcutaneous, Nemvaleukin Alfa Intravenous)

Recruiting
  • Cutaneous Melanoma
  • Mucosal Melanoma
  • Nemvaleukin Alfa Subcutaneous
  • Nemvaleukin Alfa Intravenous
  • La Jolla, California
  • +26 more
Aug 1, 2022

MDD Trial in Australia, Puerto Rico, United States (ALKS 5461, ALKS 5461 Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • ALKS 5461
  • ALKS 5461 Placebo
  • Tucson, Arizona
  • +34 more
Mar 15, 2021

Healthy Volunteers Trial in Chula Vista (ALKS 3831, Olanzapine, Placebo)

Completed
  • Healthy Volunteers
  • ALKS 3831
  • +2 more
  • Chula Vista, California
    Alkermes Investigational Site
Aug 18, 2017

Advanced Solid Tumor Trial in United States (Nemvaleukin alfa, Pembrolizumab)

Recruiting
  • Advanced Solid Tumor
  • Nemvaleukin alfa
  • Pembrolizumab
  • Grand Rapids, Michigan
  • +3 more
Aug 30, 2022

Relapsing Remitting Multiple Sclerosis Trial in Germany, Poland, United States (ALKS 8700, Dimethyl Fumarate)

Completed
Has Results
  • Relapsing Remitting Multiple Sclerosis
  • ALKS 8700
  • Dimethyl Fumarate
  • Cullman, Alabama
  • +66 more
Jul 13, 2020

Multiple Sclerosis Trial in Austin (Study Drug, Active Control, Placebo)

Completed
  • Multiple Sclerosis
  • Study Drug
  • +2 more
  • Austin, Texas
    Alkermes Investigational Site
Nov 22, 2019

MDD Trial in Australia, Canada, United States (High Dose ALKS 5461, Low Dose ALKS 5461, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • High Dose ALKS 5461
  • +2 more
  • Birmingham, Alabama
  • +48 more
Aug 2, 2019

MDD Trial in Worldwide (ALKS 5461, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • ALKS 5461
  • Placebo
  • Birmingham, Alabama
  • +43 more
Aug 2, 2019